Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.78 +2.43 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.76 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 722,348 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 45.85 -1.6 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.45 | 52 Week High | $26.84 | |||
| Open | $47.71 | 52 Week Low | $9.51 | |||
| Day High | $47.82 | P/E | N/A | |||
| Day Low | $45.79 | EPS | $-2.62 | |||
| Volume | 748,894 | |||||

